3D approaches to model the tumor microenvironment of pancreatic cancer.

作者: Elena Tomás-Bort , Markus Kieler , Shreya Sharma , Juliana B Candido , Daniela Loessner

DOI: 10.7150/THNO.42441

关键词:

摘要: In tumor engineering, 3D approaches are used to model components of the microenvironment and test new treatments. Pancreatic cancers a cancer substantial unmet need survival rates lower compared any other cancer. Bioengineering techniques increasingly applied understand unique biology pancreatic tumors design patient-specific models. Here we summarize how extracellular cellular elements their interactions have been studied in cell cultures. We review selected clinical trials, assess benefits therapies interfering with address limitations future perspectives.

参考文章(130)
Hao Yin, He, Wang, Zhang, Han, Han, Fu, Xu, Tang, A tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation International Journal of Nanomedicine. ,vol. 8, pp. 1167- 1176 ,(2013) , 10.2147/IJN.S42464
Nagaraj S. Nagathihalli, Jason A. Castellanos, Chanjuan Shi, Yugandhar Beesetty, Michelle L. Reyzer, Richard Caprioli, Xi Chen, Alex J. Walsh, Melissa C. Skala, Harold L. Moses, Nipun B. Merchant, Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer Gastroenterology. ,vol. 149, pp. 1932- 1943 ,(2015) , 10.1053/J.GASTRO.2015.07.058
Stephanie Knowlton, Sevgi Onal, Chu Hsiang Yu, Jean J. Zhao, Savas Tasoglu, Bioprinting for cancer research Trends in Biotechnology. ,vol. 33, pp. 504- 513 ,(2015) , 10.1016/J.TIBTECH.2015.06.007
Albrecht Neesse, Hana Algül, David A Tuveson, Thomas M Gress, Stromal biology and therapy in pancreatic cancer: a changing paradigm Gut. ,vol. 64, pp. 1476- 1484 ,(2015) , 10.1136/GUTJNL-2015-309304
A. Neesse, K. K. Frese, T. E. Bapiro, T. Nakagawa, M. D. Sternlicht, T. W. Seeley, C. Pilarsky, D. I. Jodrell, S. M. Spong, D. A. Tuveson, CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 12325- 12330 ,(2013) , 10.1073/PNAS.1300415110
Lola Rahib, Benjamin D. Smith, Rhonda Aizenberg, Allison B. Rosenzweig, Julie M. Fleshman, Lynn M. Matrisian, Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States Cancer Research. ,vol. 74, pp. 2913- 2921 ,(2014) , 10.1158/0008-5472.CAN-14-0155
Hitomi Hosoya, Koji Kadowaki, Michiya Matsusaki, Horacio Cabral, Hiroshi Nishihara, Hideaki Ijichi, Kazuhiko Koike, Kazunori Kataoka, Kohei Miyazono, Mitsuru Akashi, Mitsunobu R. Kano, Engineering fibrotic tissue in pancreatic cancer: a novel three-dimensional model to investigate nanoparticle delivery. Biochemical and Biophysical Research Communications. ,vol. 419, pp. 32- 37 ,(2012) , 10.1016/J.BBRC.2012.01.117
Chris S Hughes, Lynne M Postovit, Gilles A Lajoie, None, Matrigel: A complex protein mixture required for optimal growth of cell culture Proteomics. ,vol. 10, pp. 1886- 1890 ,(2010) , 10.1002/PMIC.200900758
J. J. Lee, R. M. Perera, H. Wang, D.-C. Wu, X. S. Liu, S. Han, J. Fitamant, P. D. Jones, K. S. Ghanta, S. Kawano, J. M. Nagle, V. Deshpande, Y. Boucher, T. Kato, J. K. Chen, J. K. Willmann, N. Bardeesy, P. A. Beachy, Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 111, ,(2014) , 10.1073/PNAS.1411679111
B A Boone, L Orlichenko, N E Schapiro, P Loughran, G C Gianfrate, J T Ellis, A D Singhi, R Kang, D Tang, M T Lotze, H J Zeh, The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer. Cancer Gene Therapy. ,vol. 22, pp. 326- 334 ,(2015) , 10.1038/CGT.2015.21